Bristol-Myers Squibb

NYSE: BMY · Real-Time Price · USD
48.47
0.66 (1.38%)
At close: Aug 15, 2025, 3:59 PM
48.44
-0.05%
After-hours: Aug 15, 2025, 04:11 PM EDT

Bristol-Myers Squibb Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
48.3B 45.01B 46.16B 46.38B
Cost of Revenue
20.87B 19.65B 19.67B 19.62B
Gross Profit
27.43B 25.36B 26.49B 26.76B
Operating Income
9.66B 8.47B 9.27B 9.54B
Interest Income
n/a n/a n/a n/a
Pretax Income
-8.38B 8.44B 7.71B 8.1B
Net Income
-8.95B 8.03B 6.33B 6.99B
Selling & General & Admin
7.99B 7.68B 7.81B 7.69B
Research & Development
9.78B 9.21B 9.41B 9.53B
Other Expenses
n/a n/a n/a n/a
Operating Expenses
17.77B 16.89B 17.22B 17.22B
Interest Expense
1.95B 1.17B 1.23B 1.33B
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
38.64B 36.53B 36.89B 36.84B
Income Tax Expense
554M 400M 1.37B 1.08B
Shares Outstanding (Basic)
2.03B 2.07B 2.13B 2.22B
Shares Outstanding (Diluted)
2.03B 2.08B 2.15B 2.25B
EPS (Basic)
-4.41 3.88 2.97 3.15
EPS (Diluted)
-4.41 3.86 2.95 3.12
EBITDA
3.17B 19.37B 19.22B 20.12B
EBIT
-6.43B 9.61B 8.95B 9.43B
Depreciation & Amortization
9.6B 9.76B 10.28B 10.69B